Effect of Neutral pH Icodextrin Peritoneal Dialysis Fluid on Mesothelial Cells

Chieko Higuchi1, Junko Kuriyma1, Hiroshi Sakura1

  • 1Department of Medicine, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.

Insights

Acidic icodextrin peritoneal dialysis fluid (CI) harms mesothelial cells, causing fibrosis and inhibiting growth. Neutral pH fluid (NI) is safer, with harmful effects from CI linked to low pH and glucose degradation products (GDPs).

Area of Science:

  • Nephrology
  • Cell Biology
  • Biocompatibility Studies

Background:

  • Conventional acidic icodextrin peritoneal dialysate (CI) exhibits low biocompatibility due to its acidic pH.
  • A neutral pH icodextrin dialysate (NI) has been developed, but its effects on the peritoneum remain unclear.

Purpose of the Study:

  • To investigate the impact of conventional acidic icodextrin (CI) and neutral pH icodextrin (NI) dialysates on cultured rat mesothelial cells.
  • To determine the specific roles of low pH and glucose degradation products (GDPs) in the observed cellular effects.

Main Methods:

  • Cultured rat mesothelial cells were exposed to CI and NI dialysates.
  • Gene expression of α-smooth muscle actin, collagen types 1 and 3, and P21 was analyzed using mRNA expression.
  • Cell cycle progression was assessed by examining the proportion of cells in the G2/M phase.

Main Results:

  • CI significantly increased mRNA expression for α-smooth muscle actin, collagen types 1 and 3, and P21 compared to NI.
  • Neutralizing the pH of CI did not mitigate these harmful effects.
  • The harmful effects of CI were replicated when NI was combined with glucose degradation products (GDPs) at concentrations found in CI and then acidified.
  • CI inhibited cell growth, evidenced by a lower proportion of cells in the G2/M phase of the cell cycle.

Conclusions:

  • Conventional acidic icodextrin (CI) dialysate induces epithelial-mesenchymal transition, fibrotic changes, inhibits cell growth, and promotes cell senescence in mesothelial cells.
  • These detrimental effects are attributed to the combined influence of low pH and high glucose degradation products (GDPs) in CI.
  • Neutral pH icodextrin (NI) demonstrates improved biocompatibility, suggesting it as a potentially safer alternative for peritoneal dialysis.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
831
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.3K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
871
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
532
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.5K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.8K